Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anhydrous dextrose + aspirin + epinephrine + albuterol sulfate + nitroglycerin + diphenhydramine
- Development stage
- Unknown
- Lead developer
- Best Dental Kit
- Modality
- Small Molecules
- Administration
- Intramuscular, Oral, Inhalation, Sublingual
01
Overview
Anhydrous dextrose + aspirin + epinephrine + albuterol sulfate + nitroglycerin + diphenhydramine is a **small-molecule combination emergency kit** marketed by Best Dental Kit for use in dental-office medical emergencies. The kit combines epinephrine, albuterol sulfate, nitroglycerin, diphenhydramine, aspirin, and anhydrous dextrose to address acute hypersensitivity, bronchospasm, angina-like chest pain, allergic symptoms, suspected myocardial ischemia, and hypoglycemia scenarios encountered in dental practice. For the anaphylaxis-related indication described in public labeling context, the key pharmacologically primary component is **epinephrine**, a non-selective alpha- and beta-adrenergic receptor agonist used for emergency treatment of Type I allergic reactions, including anaphylaxis, exercise-induced anaphylaxis, and idiopathic anaphylaxis. The product is best understood as a packaged emergency-response combination kit rather than a single unified fixed-dose therapeutic entity, and available information indicates it has **not been found by FDA to be safe and effective and its labeling has not been approved by FDA**.
- Brand names
- Basic Dental Emergency KitDeluxe Dental Emergency Kit
- Other names
- anhydrous dextrose + aspirin + epinephrine + albuterol sulfate + nitroglycerin + diphenhydraminedental emergency kit
02
Targets
ADRB2 (β2)HRH1 (Histamine H1 Receptor)sGC (Soluble Guanylyl Cyclase)COX
Beyond the preview
Go deeper on anhydrous dextrose + aspirin + epinephrine + albuterol sulfate + nitroglycerin + diphenhydramine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anhydrous dextrose + aspirin + epinephrine + albuterol sulfate + nitroglycerin + diphenhydramine.